BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Jun 10, 2013
Clinical News

GV1001: Phase III data

BioCentury | May 13, 2013
Emerging Company Profile

Ultimovacs: hTERT redux

Ultimovacs targeting multiple epitopes on the cancer target telomerase
BioCentury | Jun 18, 2012
Product Development

Immune springboard

New wave of cancer immunotherapies using biological insights from BMS's Yervoy
BioCentury | May 16, 2011
Company News

Geron, Kael Co. Ltd. cancer news

BioCentury | Dec 20, 2010
Clinical News

GV1001: Phase I started

BioCentury | Dec 20, 2010
Clinical News

Oncopore: Phase I started

BioCentury | Mar 8, 2010
Company News

Affitech, Kael Co. Ltd. deal

BioCentury | Jan 14, 2010
Distillery Therapeutics

Indication: Cancer

BioCentury | Jul 6, 2009
Company News

Lytix, Kael Co. Ltd. deal

Items per page:
1 - 10 of 48